Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) in patients with HR-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC) with PIK3CA mutations (m) in routine practice at several Russian centers
Zhukova Lyudmila,
Filonenko Daria,
Grechukhina Katerina,
Stepanchencko Margarita,
Orlova Rashida,
Gluzman Mark,
Vakhitova Almira,
Goryainova Alla,
Fedyanin Mikhail,
Glazkova Elena,
Stroyakovsky Daniil,
Danilova Anastasia,
Pokataev Ilya,
Stativko Olesia,
Andreyashkina Irina,
Trotsenko Ivan,
Khatkov Igor
Связанные документы (рекомендация CORE)
